Irreversible hearing loss is a catastrophic complication of treatment with aminogly-
deafness in some districts. Because of the characteristic inheritance pattern, mitochondrial DNA (mtDNA) mutations were postulated to be the cause of the deafness in these pedigrees. In 1993 it was shown that an A to G substitution at base pair 1555 of the mitochondrial 12S ribosomal RNA gene was the only mutation common to all the families with aminoglycoside ototoxicity.
We ascertained three Mongolian pedigrees from the School for the Deaf and Blind in Ulaanbaatar, all of which contained multiple affected subjects with streptomycin induced deafness in a pattern consistent with matrilineal transmission. Amplified mtDNA, obtained from transformed lymphoblastoid cell lines using previously described primers, showed the A to G point mutation in the 12S rRNA gene in two of the three families by restriction analysis as well as direct sequencing. No other example of this substitution was found among 400 control samples from Mongolians with normal hearing. We have thus confirmed the clinical relevance ofthe 1555 A to G mitochondrial mutation in the 12S rRNA gene by identifying it in affected subjects with familial aminoglycoside ototoxicity in another ethnic group. In countries where aminoglycosides are widely used, genetic counselling and screening of high risk families before the use of these drugs could have a dramatic effect on the incidence of deafness. Hereditary deafness is a heterogeneous group of genetic entities which can be distinguished by their clinical manifestations, mode of inheritance, and map location. In 10-20% of cases, deafness is associated with clinical features which permit the diagnosis of a specific syndrome while the remaining cases are considered non-syndromic. Most nonsyndromic deafness (60-70%) shows a recessive pattern of inheritance, 20-30% of cases show dominant transmission, and 2-3% are X linked.
Matrilineal or mitochondrial transmission of aminoglycoside induced deafness was first suggested by Higashi 4 This mutation occurs at a highly conserved region of the 12S rRNA gene, where aminoglycosides are known to bind and where mutations conferring aminoglycoside resistance have been described in other species.4 A small proportion of people with aminoglycoside ototoxicity but no family history of the disease also harbour the same rRNA mutation.5 Of the various other sequence changes reported by Prezant et al,4 the 663 A to G substitution in the 12S rRNA gene and the 1736 A to G substitution in the 16S rRNA gene were also present in the subjects they studied with the aminoglycoside induced toxicity. These variants were found in about 1 1% and 10% of the normal Asian population, respectively. Since four of their controls with both of these mutations received streptomycin with no ill effects, these changes are unlikely to cause deafness by themselves.
In the present study, five subjects from three Mongolian families ( fig 1) were screened for the 663 A to G and 1555 A to G changes in the 12S rRNA gene, and for the 1736 A to G change in the 16S rRNA gene. The families were ascertained through probands at the School for Deaf and Blind in Ulaanbaatar, The 1555 A to G change was absent in all these samples (fig 2B) , while the 663 and 1736nt substitutions were detected in 17/400 and 18/400 of the samples respectively (table 1) . Fourteen subjects with the 663 change also carried the 1736 change. We concluded that the 1555 A to G substitution, which is located in the highly conserved region of the 12S rRNA mitochondrial gene, is responsible for aminoglycoside sensitivity in two of the three families. Within the limits of our testing the mutations were homoplasmic in both families. This mutation was absent in the 400 controls from Mongolia. The two other mutations, 663 A to G and 1736 A to G, which are found with a frequency of 10-1 1 % in the Chinese population, were detected in four of the five affected subjects we studied, but only 4-5% of the Mongolian sample with normal hearing. The mutations were detected together in two of the three affected families, but only 3.5% of the control subjects who had normal hearing by history (x2= 16.8, 1 df, p<0.O0l). The population of Mongolia numbers about 2 million, of whom a quarter live in Ullanbatar and another 15% in much smaller urban areas. At least 40% of the rural population still lead nomadic lives as they have for centuries. The population is divided into at least 15 ethnic subgroups, the largest of which (the Hoth) accounts for about 70% of the total population. Although the distribution and frequency of the 1555 A to G change within these subgroups remains to be determined, the avoidance of the use of aminoglycosides by the matrilineal relatives of subjects with drug induced ototoxicity would provide at least one effective strategy for reducing the incidence of deafness in the Mongolian population. 
